vs
Side-by-side financial comparison of Academy Sports & Outdoors, Inc. (ASO) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Academy Sports & Outdoors, Inc. is the larger business by last-quarter revenue ($1.4B vs $783.7M, roughly 1.8× Insulet Corporation). Insulet Corporation runs the higher net margin — 13.0% vs 5.2%, a 7.8% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 3.0%). Insulet Corporation produced more free cash flow last quarter ($48.2M vs $-13.6M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs -12.2%).
Academy Sports + Outdoors is an American sporting-goods store chain with corporate offices in the Katy Distribution Center in unincorporated western Harris County, Texas, United States, near Katy and west of Houston. For 74 years, it was a privately held company owned by the Gochman family, until its May 2011 acquisition by Kohlberg Kravis Roberts. In October 2020, it was listed on NASDAQ.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
ASO vs PODD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $783.7M |
| Net Profit | $71.6M | $101.6M |
| Gross Margin | 35.7% | 72.6% |
| Operating Margin | 7.3% | 18.7% |
| Net Margin | 5.2% | 13.0% |
| Revenue YoY | 3.0% | 31.2% |
| Net Profit YoY | 8.8% | 0.9% |
| EPS (diluted) | $1.05 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $783.7M | ||
| Q3 25 | $1.6B | $706.3M | ||
| Q2 25 | $1.4B | $649.1M | ||
| Q1 25 | $1.7B | $569.0M | ||
| Q4 24 | $1.3B | $597.5M | ||
| Q3 24 | $1.5B | $543.9M | ||
| Q2 24 | $1.4B | $488.5M | ||
| Q1 24 | $1.8B | $441.7M |
| Q4 25 | $71.6M | $101.6M | ||
| Q3 25 | $125.4M | $87.6M | ||
| Q2 25 | $46.1M | $22.5M | ||
| Q1 25 | $133.6M | $35.4M | ||
| Q4 24 | $65.8M | $100.7M | ||
| Q3 24 | $142.6M | $77.5M | ||
| Q2 24 | $76.5M | $188.6M | ||
| Q1 24 | $168.2M | $51.5M |
| Q4 25 | 35.7% | 72.6% | ||
| Q3 25 | 36.0% | 72.2% | ||
| Q2 25 | 34.0% | 69.7% | ||
| Q1 25 | 32.2% | 71.9% | ||
| Q4 24 | 34.0% | 72.1% | ||
| Q3 24 | 36.1% | 69.3% | ||
| Q2 24 | 33.4% | 67.7% | ||
| Q1 24 | 33.3% | 69.5% |
| Q4 25 | 7.3% | 18.7% | ||
| Q3 25 | 10.8% | 16.7% | ||
| Q2 25 | 5.1% | 18.7% | ||
| Q1 25 | 9.2% | 15.6% | ||
| Q4 24 | 6.8% | 18.3% | ||
| Q3 24 | 12.3% | 16.2% | ||
| Q2 24 | 7.5% | 11.2% | ||
| Q1 24 | 11.4% | 12.9% |
| Q4 25 | 5.2% | 13.0% | ||
| Q3 25 | 7.8% | 12.4% | ||
| Q2 25 | 3.4% | 3.5% | ||
| Q1 25 | 8.0% | 6.2% | ||
| Q4 24 | 4.9% | 16.9% | ||
| Q3 24 | 9.2% | 14.2% | ||
| Q2 24 | 5.6% | 38.6% | ||
| Q1 24 | 9.4% | 11.7% |
| Q4 25 | $1.05 | $1.42 | ||
| Q3 25 | $1.85 | $1.24 | ||
| Q2 25 | $0.68 | $0.32 | ||
| Q1 25 | $1.85 | $0.50 | ||
| Q4 24 | $0.92 | $1.38 | ||
| Q3 24 | $1.95 | $1.08 | ||
| Q2 24 | $1.01 | $2.59 | ||
| Q1 24 | $2.19 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $289.5M | — |
| Total DebtLower is stronger | — | $930.8M |
| Stockholders' EquityBook value | $2.1B | $1.5B |
| Total Assets | $5.4B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $289.5M | — | ||
| Q3 25 | $300.9M | — | ||
| Q2 25 | $285.1M | — | ||
| Q1 25 | $288.9M | — | ||
| Q4 24 | $296.0M | — | ||
| Q3 24 | $324.6M | — | ||
| Q2 24 | $378.1M | — | ||
| Q1 24 | $347.9M | — |
| Q4 25 | — | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $1.9B | $1.5B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $2.0B | $1.2B | ||
| Q3 24 | $2.0B | $1.1B | ||
| Q2 24 | $1.9B | $998.4M | ||
| Q1 24 | $2.0B | $790.7M |
| Q4 25 | $5.4B | $3.2B | ||
| Q3 25 | $5.3B | $3.0B | ||
| Q2 25 | $5.2B | $3.5B | ||
| Q1 25 | $4.9B | $3.5B | ||
| Q4 24 | $5.1B | $3.1B | ||
| Q3 24 | $4.9B | $3.0B | ||
| Q2 24 | $4.9B | $2.9B | ||
| Q1 24 | $4.7B | $2.6B |
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $49.0M | $183.3M |
| Free Cash FlowOCF − Capex | $-13.6M | $48.2M |
| FCF MarginFCF / Revenue | -1.0% | 6.2% |
| Capex IntensityCapex / Revenue | 4.5% | 17.2% |
| Cash ConversionOCF / Net Profit | 0.68× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $191.4M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.0M | $183.3M | ||
| Q3 25 | $78.6M | $125.7M | ||
| Q2 25 | $157.5M | $196.5M | ||
| Q1 25 | $140.2M | $63.8M | ||
| Q4 24 | $96.9M | $147.7M | ||
| Q3 24 | $91.3M | $98.5M | ||
| Q2 24 | $199.7M | $96.5M | ||
| Q1 24 | $234.7M | $87.6M |
| Q4 25 | $-13.6M | $48.2M | ||
| Q3 25 | $21.8M | $100.1M | ||
| Q2 25 | $106.6M | $177.9M | ||
| Q1 25 | $76.4M | $51.5M | ||
| Q4 24 | $34.4M | $94.1M | ||
| Q3 24 | $50.1M | $71.8M | ||
| Q2 24 | $167.4M | $74.0M | ||
| Q1 24 | $178.9M | $65.5M |
| Q4 25 | -1.0% | 6.2% | ||
| Q3 25 | 1.4% | 14.2% | ||
| Q2 25 | 7.9% | 27.4% | ||
| Q1 25 | 4.6% | 9.1% | ||
| Q4 24 | 2.6% | 15.7% | ||
| Q3 24 | 3.2% | 13.2% | ||
| Q2 24 | 12.3% | 15.1% | ||
| Q1 24 | 10.0% | 14.8% |
| Q4 25 | 4.5% | 17.2% | ||
| Q3 25 | 3.5% | 3.6% | ||
| Q2 25 | 3.8% | 2.9% | ||
| Q1 25 | 3.8% | 2.2% | ||
| Q4 24 | 4.6% | 9.0% | ||
| Q3 24 | 2.7% | 4.9% | ||
| Q2 24 | 2.4% | 4.6% | ||
| Q1 24 | 3.1% | 5.0% |
| Q4 25 | 0.68× | 1.80× | ||
| Q3 25 | 0.63× | 1.43× | ||
| Q2 25 | 3.42× | 8.73× | ||
| Q1 25 | 1.05× | 1.80× | ||
| Q4 24 | 1.47× | 1.47× | ||
| Q3 24 | 0.64× | 1.27× | ||
| Q2 24 | 2.61× | 0.51× | ||
| Q1 24 | 1.40× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASO
| Outdoors | $445.1M | 32% |
| Apparel | $349.8M | 25% |
| Footwear | $292.4M | 21% |
| Sports And Recreation | $288.7M | 21% |
| Other | $7.6M | 1% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
